2,4-Thiazolidinedione,5-[3-ethoxy-4-(pentyloxy)phenyl]-

MSDS  :
 2,4-Thiazolidinedione,
5-(3-ethoxy-4-(pentyloxy)phenyl)-
CAS  
:
 79714-31-1
SYNONYMS  
:
 * CT 112
* 5-(3-Ethoxy-4-(pentyloxy)phenyl)-2,4-thiazolidinedione

Catalog of Chemical Suppliers, Buyers, Custom Synthesis Companies And Equipment Manufacturers
[ 2,4-Thiazolidinedione,5-(3-ethoxy-4-(pentyloxy)phenyl)- 79714-31-1 ]
                     *** CHEMICAL IDENTIFICATION ***

RTECS NUMBER            : XJ5813282
CHEMICAL NAME           : 2,4-Thiazolidinedione,
                          5-(3-ethoxy-4-(pentyloxy)phenyl)-
CAS REGISTRY NUMBER     : 79714-31-1
LAST UPDATED            : 199703
DATA ITEMS CITED        : 6
MOLECULAR FORMULA       : C16-H21-N-O4-S
MOLECULAR WEIGHT        : 323.44
COMPOUND DESCRIPTOR     : Drug
SYNONYMS/TRADE NAMES :
   * CT 112
   * 5-(3-Ethoxy-4-(pentyloxy)phenyl)-2,4-thiazolidinedione
 
                       *** HEALTH HAZARD DATA ***
 
                        ** ACUTE TOXICITY DATA **
 
TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 4330 mg/kg
TOXIC EFFECTS :
   Sense Organs and Special Senses (Eye) - lacrimation
   Behavioral - altered sleep time (including change in righting reflex)
   Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
   EPXXDW European Patent Application. (U.S. Patent and Trademark Office,
   Foreign Patents, Washington, DC 20231)  Volume(issue)/page/year: #0170237
 
TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 490 mg/kg
TOXIC EFFECTS :
   Sense Organs and Special Senses (Eye) - lacrimation
   Behavioral - altered sleep time (including change in righting reflex)
   Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
   EPXXDW European Patent Application. (U.S. Patent and Trademark Office,
   Foreign Patents, Washington, DC 20231)  Volume(issue)/page/year: #0170237
 
TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 3210 mg/kg
TOXIC EFFECTS :
   Sense Organs and Special Senses (Eye) - lacrimation
   Behavioral - altered sleep time (including change in righting reflex)
   Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
   EPXXDW European Patent Application. (U.S. Patent and Trademark Office,
   Foreign Patents, Washington, DC 20231)  Volume(issue)/page/year: #0170237
 
TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 2150 mg/kg
TOXIC EFFECTS :
   Sense Organs and Special Senses (Eye) - lacrimation
   Behavioral - altered sleep time (including change in righting reflex)
   Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
   EPXXDW European Patent Application. (U.S. Patent and Trademark Office,
   Foreign Patents, Washington, DC 20231)  Volume(issue)/page/year: #0170237
 
TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 500 mg/kg
TOXIC EFFECTS :
   Sense Organs and Special Senses (Eye) - lacrimation
   Behavioral - altered sleep time (including change in righting reflex)
   Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
   EPXXDW European Patent Application. (U.S. Patent and Trademark Office,
   Foreign Patents, Washington, DC 20231)  Volume(issue)/page/year: #0170237
 
TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 1720 mg/kg
TOXIC EFFECTS :
   Sense Organs and Special Senses (Eye) - lacrimation
   Behavioral - altered sleep time (including change in righting reflex)
   Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
   EPXXDW European Patent Application. (U.S. Patent and Trademark Office,
   Foreign Patents, Washington, DC 20231)  Volume(issue)/page/year: #0170237
 
                            *** END OF RECORD ***
;

Recommended suppliers

Amadis Chemical Co., Ltd.

China (Mainland) Assessed Supplier

Risarestat;79714-31-1

  • Assay:97%
  • Appearance:Powder or liquid
  • Package:According to customer
  • Storage:Store in a tightly closed container, in a cool and dry place.
  • Transportation:Fedex,DHL,TNT,BY SEA and BY AIR
  • Application:Medicinal ChemistryBiomedicinePharmaceutical intermediatesChemistry experimentBiological experimentsChemical reagentFor R&D use only.
Contact Supplier

Henan Tianfu Chemical Co., Ltd.

China (Mainland) Assessed Supplier

Risarestat

  • Assay:99%
  • Appearance:
  • Package:as per buyers
  • Storage:R.T.
  • Transportation:by air/sea
  • Application:intermediate
Contact Supplier

ZHEJIANG JIUZHOU CHEM CO.,LTD

China (Mainland) Assessed Supplier

CT 112

  • Assay:99%
  • Appearance:White powder
  • Package:200/Kilograms
  • Storage:Sealed and preserved
  • Transportation:By sea
  • Application:healing drugs
Contact Supplier

Shanghai Haoyuan Chemexpress Co., Ltd.

China (Mainland) Assessed Supplier

2,4-Thiazolidinedione,5-[3-ethoxy-4-(pentyloxy)phenyl]-

  • Assay:
  • Appearance:
  • Package:
  • Storage:
  • Transportation:
  • Application:
Contact Supplier

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View